Concepedia

Gabriel Mak

GM

12

Publications

351

Citations

11

H-Index

2014

Active since

Affiliations

Sarah Cannon Research Institute(Current)

University College London

AstraZeneca (Japan)

Newcastle University

Shizuoka Cancer Center

Gabriel Mak is an author at Sarah Cannon Research Institute specializing in radiation oncology, oncology, and cancer therapeutics.

Top concepts

Publications per year

2014–2023

12

Publications

12

A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours

Gabriel Mak, Jean‐Charles Soria, Sarah P. Blagden et al. · British Journal of Cancer · 2019 · 99 citations · Full text

Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

Michele Moschetta, Mario Uccello, Benjamin Kasenda et al. · BioMed Research International · 2017 · 65 citations · Full text

Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study

Suresh Senan, Isamu Okamoto, Gyeong‐Won Lee et al. · Clinical Lung Cancer · 2019 · 64 citations · Full text

Early clinical efficacy of TAS-120, a covalently bound FGFR inhibitor, in patients with cholangiocarcinoma

Lipika Goyal, Hendrik-Tobias Arkenau, Ben Tran et al. · Annals of Oncology · 2017 · 20 citations

, , +8

Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation

Gabriel Mak, Melvin Chin, Najmun Nahar et al. · BMC Research Notes · 2014 · 16 citations · Full text

Rows per page

1–5 of 12